Entering the era of proteomics in rheumatology

Expert Opinion on Drug Discovery

Volumn 1, Issue 6, 2006, Pages 539-548

  Lambrecht, Stijn ^a   Deforce, Dieter ^b   Elewaut, Dirk ^b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

arthritis; biomarkers; mass spectrometry; proteomics; rheumatology

Indexed keywords

EID: 80052565770     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.1.6.539     Document Type: Review

References (57)

1. GRAVES PR, HAYSTEAD TA: Molecular biologists guide to proteomics. Microbiol. Mol. Biol. Rev. (2002) 66(1):39-63.
2. PANDEY A, MANN M: Proteomics to study genes and genomes. Nature (2000) 405(6788):837-846.
3. OFARRELL PH: High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. (1975) 250(10):4007-4021.
4. KLOSE J: Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik (1975) 26(3):231-243.
5. GORG A, WEISS W, DUNN MJ: Current two-dimensional electrophoresis technology for proteomics. Proteomics (2004) 4(12):3665-3685.
6. TAYLOR RS, WU CC, HAYS LG et al.: Proteomics of rat liver Golgi complex: minor proteins are identified through sequential fractionation. Electrophoresis (2000) 21(16):3441-3459.
7. BJORHALL K, MILIOTIS T, DAVIDSSON P: Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics (2005) 5(1):307-317.
8. RABILLOUD T: Use of thiourea to increase the solubility of membrane proteins in two-dimensional electrophoresis. Electrophoresis (1998) 19(5):758-760.
9. MOLLOY MP, HERBERT BR, WALSH BJ et al.: Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis (1998) 19(5):837-844.
10. MEHTA AI, ROSS S, LOWENTHAL MS et al.: Biomarker amplification by serum carrier protein binding. Dis. Markers (2003) 19(1):1-10.
11. RIGHETTI P, CASTAGNA A, ANTONIOLI P, BOSCHETTI E: Prefractionation techniques in proteome analysis: the mining tools of the third millennium. Electrophoresis (2005) 26(2):297-319.
12. SHAW MM, RIEDERER BM: Sample preparation for two-dimensional gel electrophoresis. Proteomics (2003) 3(8):1408-1417.
13. BJELLQVIST B, PASQUALI C, RAVIER F, SANCHEZ JC, HOCHSTRASSER D: A nonlinear wide-range immobilized pH gradient for two-dimensional electrophoresis and its definition in a relevant pH scale. Electrophoresis (1993) 14(12):1357-1365.
14. GORG A, OBERMAIER C, BOGUTH G et al.: The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis (2000) 21(6):1037-1053.
15. PATTON WF: A thousand points of light: the application of fluorescence detection technologies to two-dimensional gel electrophoresis and proteomics. Electrophoresis (2000) 21(6):1123-1144.
16. BERGGREN K, CHERNOKALSKAYA E, STEINBERG TH et al.: Background-free, high sensitivity staining of proteins in oneand two-dimensional sodium dodecyl sulfate-polyacrylamide gels using a luminescent ruthenium complex. Electrophoresis (2000) 21(12):2509-2521.
17. SCHULENBERG B, AGGELER R, BEECHEM JM, CAPALDI RA, PATTON WF: Analysis of steady-state protein phosphorylation in mitochondria using a novel fluorescent phosphosensor dye. J. Biol. Chem. (2003) 278(29):27251-27255.
18. STEINBERG TH, PRETTY ON TOP K, BERGGREN KN et al.: Rapid and simple single nanogram detection of glycoproteins in polyacrylamide gels and on electroblots. Proteomics (2001) 1(7):841-855.
19. UNLU M, MORGAN ME, MINDEN JS: Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis (1997) 18(11):2071-2077.
20. MANN M, HENDRICKSON RC, PANDEY A: Analysis of proteins and proteomes by mass spectrometry. Annu. Rev. Biochem. (2001) 70:437-473.
21. WASHBURN M, WOLTERS D, YATES J: Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. (2001) 19(3):242-247.
22. BEAUSOLEIL SA, JEDRYCHOWSKI M, SCHWARTZ D et al.: Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. USA (2004) 101(33):12130-12135.
23. KRIJGSVELD J, KETTING R, MAHMOUDI T et al.: Metabolic labeling of C-elegans and D-melanogaster for quantitative proteomics. Nat. Biotechnol. (2003) 21(8):927-931.
24. GYGI S, RIST B, GERBER S et al.: Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. (1999) 17(10):994-999.
25. ROSS PL, HUANG YN, MARCHESE JN et al.: Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics (2004) 3(12):1154-1169.
26. WEINBERGER SR, DALMASSO EA, FUNG ET: Current achievements using ProteinChip Array technology. Curr. Opin. Chem. Biol. (2002) 6(1):86-91.
27. GULMANN C, SHEEHAN KM, KAY EW, LIOTTA LA, PETRICOIN EF III: Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer. J. Pathol. (2006) 208(5):595-606.
28. HAAB BB: Antibody arrays in cancer research. Mol. Cell Proteomics (2005) 4(4):377-383.
29. PAWELETZ CP, CHARBONEAU L, BICHSEL VE et al.: Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene (2001) 20(16):1981-1989.
30. JOBERTY G, PERLUNGHER R, SHEFFIELD P et al.: Borg proteins control septin organization and are negatively regulated by Cdc42. Nat. Cell Biol. (2001) 3(10):861-866.
31. FIELDS S, SONG O: A novel genetic system to detect protein-protein interactions. Nature (1989) 340(6230):245-246.
32. BORCH J, JORGENSEN TJ, ROEPSTORFF P: Mass spectrometric analysis of protein interactions. Curr. Opin. Cell Biol. (2005) 9(5):509-516.
33. GOUGH AK, LILLEY J, EYRE S, HOLDER RL, EMERY P: Generalised bone loss in patients with early rheumatoid arthritis. Lancet (1994) 344(8914):23-27.
34. DEODHAR AA, BRABYN J, PANDE I, SCOTT DL, WOOLF AD: Hand bone densitometry in rheumatoid arthritis, a five year longitudinal study: an outcome measure and a prognostic marker. Ann. Rheum. Dis. (2003) 62(8):767-770.
35. DOTZLAW H, SCHULZ M, EGGERT M, NEECK G: A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim. Biophys. Acta (2004) 1696(1):121-129.
36. DRYNDA S, RINGEL B, KEKOW M et al.: Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFá therapy. Pathol. Res. Pract. (2004) 200(2):165-171.
37. SINZ A, BANTSCHEFF M, MIKKAT S et al.: Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis (2002) 23(19):3445-3456.
38. YAMAGIWA H, SARKAR G, CHARLESWORTH MC, MCCORMICK DJ, BOLANDER ME: Two-dimensional gel electrophoresis of synovial fluid: method for detecting candidate protein markers for osteoarthritis. J. Orthop. Sci. (2003) 8(4):482-490.
39. SMITH MA, BAINS SK, BETTS JC, CHOY EH, ZANDERS ED: Use of two-dimensional gel electrophoresis to measure changes in synovial fluid proteins from patients with rheumatoid arthritis treated with antibody to CD4. Clin. Diagn. Lab. Immunol. (2001) 8(1):105-111.
40. MIYAMAE T, MALEHORN DE, LEMSTER B et al.: Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy. Arthritis Res. Ther. (2005) 7(4):R746-R755.
41. UCHIDA T, FUKAWA A, UCHIDA M, FUJITA K, SAITO K: Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid. J. Res. (2002) 1(6):495-499.
42. DE SENY D, FILLET M, MEUWIS MA et al.: Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum. (2005) 52(12):3801-3812.
43. LIAO H, WU J, KUHN E et al.: Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum. (2004) 50(12):3792-3803.
44. TILLEMAN K, VAN BENEDEN K, DHONDT A et al.: Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry. Proteomics (2005) 5(8):2247-2257.
45. DASURI K, ANTONOVICI M, CHEN K et al.: The synovial proteome: analysis of fibroblast-like synoviocytes. Arthritis Res. Ther. (2004) 6(2):R161-R168.
46. RUIZ-ROMERO C, LOPEZ-ARMADA MJ, BLANCO FJ: Proteomic characterization of human normal articular chondrocytes: a novel tool for the study of osteoarthritis and other rheumatic diseases. Proteomics (2005) 5(12):3048-3059.
47. RUIZ-ROMERO C, LOPEZ-ARMADA MJ, BLANCO FJ: Mitochondrial proteomic characterization of human normal articular chondrocytes. Osteoarthritis Cartilage (2006) 14(6):507-518.
48. HERMANSSON M, SAWAJI Y, BOLTON M et al.: Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin betaA (activin A), a regulatory molecule for chondrocytes. J. Biol. Chem. (2004) 279(42):43514-43521.
49. AVOUAC J, GOSSEC L, DOUGADOS M: Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann. Rheum. Dis. (2006) 65(7):845-851.
50. ROBINSON WH, DIGENNARO C, HUEBER W et al.: Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. (2002) 8(3):295-301.
51. HUEBER W, KIDD BA, TOMOOKA BH et al.: Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum. (2005) 52(9):2645-2655.
52. LI QZ, XIE C, WU T et al.: Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J. Clin. Invest. (2005) 115(12):3428-3439.
53. UKAJI F, KITAJIMA I, KUBO T et al.: Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to "denatured" aldolase A in the osteoblast-like cell line, MG-63. Ann. Rheum. Dis. (1999) 58(3):169-174.
54. SAULOT V, VITTECOQ O, CHARLIONET R et al.: Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum. (2002) 46(5):1196-1201.
55. YUAN GH, MASUKO-HONGO K, KATO T, NISHIOKA K: Immunologic intervention in the pathogenesis of osteoarthritis. Arthritis Rheum. (2003) 48(3):602-611.
56. XIANG Y, SEKINE T, NAKAMURA H et al.: Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. Arthritis Rheum. (2004) 50(5):1511-1521.
57. XIANG Y, SEKINE T, NAKAMURA H et al.: Fibulin-4 is a target of autoimmunity predominantly in patients with osteoarthritis. J. Immunol. (2006) 176(5):3196-3204.